2563 — Beijing Biostar Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.10bn
- HK$3.10bn
- CNY71.87m
Annual cashflow statement for Beijing Biostar Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -161 | -190 | -144 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 59.6 | 6.22 | -19.3 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 11 | 22 | 50.6 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -79.4 | -151 | -103 |
| Capital Expenditures | -32.7 | -27.8 | -40.8 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -114 | 159 | 95 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -147 | 131 | 54.2 |
| Financing Cash Flow Items | 4.66 | -0.125 | -11.2 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 3.53 | -1.13 | 202 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -208 | -22 | 152 |